Professor, Medicine, Emory University School of Medicine
Endocrinology
Dr. Roberto Pacifici, MD
|
|
Give Review
Roberto Pacifici is an expert in the field of Endocrinology. He received awards:"Elected Member". Dr. Roberto Pacifici is a published doctor. He published 38 publications, including: 'Erythropoietin receptor and STAT5-specific pathways promote SKT6 cell hemoglobinization.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- IL-17A Is Increased in Humans with Primary Hyperparathyroidism and Mediates PTH-Induced Bone Loss in Mice.
- The Sclerostin-Independent Bone Anabolic Activity of Intermittent PTH Treatment Is Mediated by T-Cell-Produced Wnt10b.
- Role of T cells in the modulation of PTH action: physiological and clinical significance.
- Ovariectomy expands murine short-term hemopoietic stem cell function through T cell expressed CD40L and WNT10B.
- Superoxide dismutase is preferentially degraded by a proteolytic system from red blood cells following oxidative modification by hydrogen peroxide.
- Hybrid tyrosine kinase/cytokine receptors transmit mitogenic signals in response to ligand.
- Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited.
- Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome.
- Erythropoietin receptor and STAT5-specific pathways promote SKT6 cell hemoglobinization.
- Transient adaptation of oxidative stress in mammalian cells.
- Role of T cells in ovariectomy induced bone loss-revisited.
- Skeletal fluorosis from brewed tea.
- Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand.
- Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss.
- The immune system and bone.
- T cells: critical bone regulators in health and disease.
- Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss.
- Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss.
- T lymphocytes amplify the anabolic activity of Parathyroid hormone through Wnt10b signaling.
- T cells potentiate PTH-induced cortical bone loss through CD40L signaling.
- T cells: unexpected players in the bone loss induced by estrogen Deficiency and in basal bone homeostasis.
- Stability studies of principal illicit drugs in oral fluid: preparation of reference materials for external quality assessment schemes.
- Estrogen Deficiency, T cells and bone loss.
- Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation.
- T cells and post menopausal Osteoporosis in murine models.
- IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.
- IL-7 drives T cell-mediated bone loss following ovariectomy.
- Estrogen regulation of immune cell bone interactions.
- Estrogen Deficiency and bone loss: an inflammatory tale.
- The role of T lymphocytes in bone Metabolism.
- An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen Deficiency.
- Role of the immune system in postmenopausal bone loss.
- Estrogen prevents bone loss through transforming growth factor beta signaling in T cells.
- Estrogen Deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.
- Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study.
- IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and Tumor necrosis factor alpha from T cells.
- Increased production of IL-7 uncouples bone formation from bone resorption during estrogen Deficiency.
Conditions Treated
- Calcium Metabolism Disorders
- Hypercalcemia
- HyperParathyroidism
- Hypothyroidism
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Elected Member
Education
-
Barnes-Jewish Hospital -
University of Perugia Faculty of Medicine
Hospital
-
Emory University Hospital -
Emory University Hospital Midtown
Drug Facts
| NPI NUMBER | 1861400509 | |
| NPPES Provider LastName | PACIFICI | |
| NPPES Provider FirstName | ROBERTO | |
| NPPES Provider ZIPCode | 303221013 | |
| NPPES Provider State | GA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 120.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861400509 |
| Last Name Of The Provider | PACIFICI |
| First Name Of The Provider | ROBERTO |
| View All |
Similar Doctors
|
|
Dr. Lawrence S. Phillips, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Thomas R. Ziegler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Priya Dayamani, MD
This Doctor is OpenDoctor Recommended.
|